SAIPARENTBSESai Parenterals LtdMediumNeutral
Announced Mon, 6 Jul · 15:19 IST

Board appoints auditors and authorises CMD to explore growth opportunities

Management Changes View source PDF

SAIPARENT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹620.55
prior close
₹609.75
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0-3.6-4.8-4.3-5.0-5.4-8.5-10.1
Up moveDown movePending
AI summary

Sai Parenterals board on July 6, 2026 approved three auditor appointments: Aakanksha Dubey and Co. as Secretarial Auditors for 5 years (FY 2026-27 to 2030-31), NSVR and Associates LLP as Internal Auditors for FY 2026-27, and Sai Krishna and Associates as Cost Auditors for FY 2026-27. The board also authorised CMD Anil Kumar Karusala to identify and explore organic and inorganic growth opportunities in existing and strategic areas. All appointments are subject to shareholder approval where applicable.

Likely market impact

Routine governance update; auditor refresh and broader growth mandate for CMD could signal upcoming expansion or acquisitions.